H.B. Fuller (NYSE:FUL) Price Target Cut to $72.00 by Analysts at Deutsche Bank Aktiengesellschaft

H.B. Fuller (NYSE:FULGet Free Report) had its target price reduced by research analysts at Deutsche Bank Aktiengesellschaft from $75.00 to $72.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the specialty chemicals company’s stock. Deutsche Bank Aktiengesellschaft’s price objective points to a potential upside of 15.53% from the company’s previous close.

FUL has been the subject of several other reports. Citigroup dropped their price target on H.B. Fuller from $78.00 to $68.00 and set a “neutral” rating for the company in a research note on Friday, January 3rd. Vertical Research lowered shares of H.B. Fuller from a “buy” rating to a “hold” rating in a report on Monday, January 6th. Finally, JPMorgan Chase & Co. reduced their price target on shares of H.B. Fuller from $70.00 to $60.00 and set an “underweight” rating on the stock in a research report on Friday, January 17th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $75.60.

View Our Latest Stock Analysis on FUL

H.B. Fuller Trading Up 0.9 %

H.B. Fuller stock opened at $62.32 on Wednesday. The stock has a 50-day moving average price of $69.69 and a 200 day moving average price of $76.40. H.B. Fuller has a 52 week low of $60.96 and a 52 week high of $87.67. The stock has a market cap of $3.40 billion, a PE ratio of 26.98, a P/E/G ratio of 1.19 and a beta of 1.43. The company has a current ratio of 1.81, a quick ratio of 1.16 and a debt-to-equity ratio of 1.10.

H.B. Fuller (NYSE:FULGet Free Report) last released its earnings results on Wednesday, January 15th. The specialty chemicals company reported $0.92 earnings per share for the quarter, missing the consensus estimate of $1.00 by ($0.08). H.B. Fuller had a return on equity of 12.01% and a net margin of 3.65%. The business had revenue of $923.00 million for the quarter, compared to analysts’ expectations of $916.84 million. During the same quarter last year, the company posted $1.32 earnings per share. The business’s quarterly revenue was up 2.2% compared to the same quarter last year. Equities research analysts predict that H.B. Fuller will post 4.07 earnings per share for the current fiscal year.

Institutional Trading of H.B. Fuller

A number of hedge funds have recently made changes to their positions in the company. Wesbanco Bank Inc. grew its holdings in H.B. Fuller by 41.2% during the 4th quarter. Wesbanco Bank Inc. now owns 13,700 shares of the specialty chemicals company’s stock valued at $924,000 after purchasing an additional 4,000 shares in the last quarter. S&CO Inc. grew its stake in shares of H.B. Fuller by 0.3% during the third quarter. S&CO Inc. now owns 267,192 shares of the specialty chemicals company’s stock valued at $21,209,000 after acquiring an additional 920 shares in the last quarter. Marshall Wace LLP increased its position in shares of H.B. Fuller by 9.9% during the second quarter. Marshall Wace LLP now owns 290,005 shares of the specialty chemicals company’s stock worth $22,319,000 after acquiring an additional 26,239 shares during the last quarter. Lord Abbett & CO. LLC lifted its stake in shares of H.B. Fuller by 79.8% in the third quarter. Lord Abbett & CO. LLC now owns 730,058 shares of the specialty chemicals company’s stock worth $57,952,000 after acquiring an additional 324,056 shares in the last quarter. Finally, Geode Capital Management LLC boosted its holdings in H.B. Fuller by 1.5% in the third quarter. Geode Capital Management LLC now owns 1,258,752 shares of the specialty chemicals company’s stock valued at $99,939,000 after purchasing an additional 18,734 shares during the last quarter. Hedge funds and other institutional investors own 95.93% of the company’s stock.

About H.B. Fuller

(Get Free Report)

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.

Featured Stories

Analyst Recommendations for H.B. Fuller (NYSE:FUL)

Receive News & Ratings for H.B. Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H.B. Fuller and related companies with MarketBeat.com's FREE daily email newsletter.